68 related articles for article (PubMed ID: 12116055)
21. Physical performance in long-term survivors of acute leukaemia in childhood.
Black P; Gutjahr P; Stopfkuchen H
Eur J Pediatr; 1998 Jun; 157(6):464-7. PubMed ID: 9667400
[TBL] [Abstract][Full Text] [Related]
22. Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study.
Sieswerda E; Kremer LC; Vidmar S; De Bruin ML; Smibert E; Sjöberg G; Cheung MM; Weintraub RG
Pediatr Blood Cancer; 2010 Apr; 54(4):579-84. PubMed ID: 20014238
[TBL] [Abstract][Full Text] [Related]
23. Monitoring long-term treatment with pegylated liposomal doxorubicin: how important is intensive cardiac follow-up?
Grenader T; Goldberg A; Gabizon A
Anticancer Drugs; 2010 Oct; 21(9):868-71. PubMed ID: 20679886
[TBL] [Abstract][Full Text] [Related]
24. Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography.
Villani F; Meazza R; Materazzo C
Anticancer Res; 2006; 26(1B):797-801. PubMed ID: 16739356
[TBL] [Abstract][Full Text] [Related]
25. Anthracycline induced cardiac toxicity in pediatric Ewing sarcoma: a longitudinal study.
Brown TR; Vijarnsorn C; Potts J; Milner R; Sandor GG; Fryer C
Pediatr Blood Cancer; 2013 May; 60(5):842-8. PubMed ID: 23382019
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.
Adams MJ; Lipsitz SR; Colan SD; Tarbell NJ; Treves ST; Diller L; Greenbaum N; Mauch P; Lipshultz SE
J Clin Oncol; 2004 Aug; 22(15):3139-48. PubMed ID: 15284266
[TBL] [Abstract][Full Text] [Related]
27. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy.
Pinarli FG; Oğuz A; Tunaoğlu FS; Karadeniz C; Gökçora N; Elbeg S
Pediatr Blood Cancer; 2005 Apr; 44(4):370-7. PubMed ID: 15602715
[TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin.
Villani F; Galimberti M; Comazzi R; Crippa F; Bonfante V; Ferrari L; Pacciarini MA
Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):185-9. PubMed ID: 3403095
[TBL] [Abstract][Full Text] [Related]
29. Echocardiographic surveillance for asymptomatic late-onset anthracycline cardiomyopathy in childhood cancer survivors.
Abosoudah I; Greenberg ML; Ness KK; Benson L; Nathan PC
Pediatr Blood Cancer; 2011 Sep; 57(3):467-72. PubMed ID: 21280201
[TBL] [Abstract][Full Text] [Related]
30. Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy.
Pein F; Sakiroglu O; Dahan M; Lebidois J; Merlet P; Shamsaldin A; Villain E; de Vathaire F; Sidi D; Hartmann O
Br J Cancer; 2004 Jul; 91(1):37-44. PubMed ID: 15162142
[TBL] [Abstract][Full Text] [Related]
31. Assessment of late cardiotoxicity of pirarubicin (THP) in children with acute lymphoblastic leukemia.
Shimomura Y; Baba R; Watanabe A; Horikoshi Y; Asami K; Hyakuna N; Iwai A; Matsushita T; Yamaji K; Hori T; Tsurusawa M;
Pediatr Blood Cancer; 2011 Sep; 57(3):461-6. PubMed ID: 21298773
[TBL] [Abstract][Full Text] [Related]
32. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood.
Lipshultz SE; Colan SD; Gelber RD; Perez-Atayde AR; Sallan SE; Sanders SP
N Engl J Med; 1991 Mar; 324(12):808-15. PubMed ID: 1997853
[TBL] [Abstract][Full Text] [Related]
33. Regional cardiac wall motion abnormalities during and shortly after anthracyclines therapy.
Kapusta L; Groot-Loonen J; Thijssen JM; DeGraaf R; Daniëls O
Med Pediatr Oncol; 2003 Nov; 41(5):426-35. PubMed ID: 14515381
[TBL] [Abstract][Full Text] [Related]
34. [Frequency analysis of the QRS complex: a new method of detecting development of myocardial damage after anthracycline cytostatics].
Mladosievicova B; Foltinova A; Paulovic P; Petrasova H; Hulin I
Bratisl Lek Listy; 2000; 101(7):409-11. PubMed ID: 11059111
[TBL] [Abstract][Full Text] [Related]
35. [Monitoring of cardiac function in anthracycline therapy in childhood].
Jensen E; Richter R; Mittler U; Kluba U; Aumann V
Padiatr Grenzgeb; 1984; 23(6):455-65. PubMed ID: 6598219
[No Abstract] [Full Text] [Related]
36. Doxorubicin induces senescence and impairs function of human cardiac progenitor cells.
Piegari E; De Angelis A; Cappetta D; Russo R; Esposito G; Costantino S; Graiani G; Frati C; Prezioso L; Berrino L; Urbanek K; Quaini F; Rossi F
Basic Res Cardiol; 2013 Mar; 108(2):334. PubMed ID: 23411815
[TBL] [Abstract][Full Text] [Related]
37. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer.
Hayakawa H; Komada Y; Hirayama M; Hori H; Ito M; Sakurai M
Med Pediatr Oncol; 2001 Jul; 37(1):4-9. PubMed ID: 11466716
[TBL] [Abstract][Full Text] [Related]
38. Signal-averaged ECG in patients after anthracycline therapy for childhood cancer.
Mladosievicová B; Foltinová A; Bernadic M; Hubka P; Petrásová H; Hulín I
Neoplasma; 1998; 45(1):40-5. PubMed ID: 9605001
[TBL] [Abstract][Full Text] [Related]
39. Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study.
Sorensen K; Levitt GA; Bull C; Dorup I; Sullivan ID
Cancer; 2003 Apr; 97(8):1991-8. PubMed ID: 12673729
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma.
Longhi A; Ferrari S; Bacci G; Specchia S
Anticancer Drugs; 2007 Jul; 18(6):737-44. PubMed ID: 17762406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
